Novo Nordisk's semaglutide ... ahead of other new products such as obesity drug Saxenda (liraglutide). Meanwhile, the start of phase III trials of oral semaglutide is also a boost for Novo ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...